News
About a dozen activists from the Extinction Rebellion climate group briefly occupied the entrance lobby of French bank BNP ...
The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ...
The duality is a hallmark of Greater Boston’s lab market these days. Bright spots surely remain, such as big new lab ...
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
One of the nation’s largest real estate companies has transferred its corporate registration back to Indiana from the state ...
Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...
One of the nation’s largest real estate companies has transferred its corporate registration back to Indiana from the state ...
Online prescriptions – for everything from weight loss to medicinal cannabis – is now a big business backed by Woolworths and ...
14h
Zacks Investment Research on MSN3 Stocks Targeting Weight Loss Market With Cannabinoid-Based TherapiesThe obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This ...
10h
MarketBeat on MSN3 Trades Members of Congress Are Making Right NowWhether or not members of Congress should be allowed to buy or sell stocks is another topic. Retail investors should keep ...
Everything from a live-action Disney remake to the newest Mission Impossible movie will be hitting screens this summer.
Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results